Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rick Turner

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of the American Society of Hypertension : JASH|May 17, 2015
Renal denervation therapy for hypertension: pathways for moving development forwardWilliam B White, Zorina S Galis, Jeffrey Henegar, et al.
American Heart Journal|February 3, 2015
Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac Safety Research ConsortiumJonathan H Seltzer, J Rick Turner, Mary Jane Geiger, et al.
American Heart Journal|December 11, 2017
Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association-cardiac safety research consortium cosponsored think tankHarry A Seifert, Raleigh E Malik, Mondira Bhattacharya, et al.
Journal of the American Society of Hypertension : JASH|November 25, 2014
Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013William B White, J Rick Turner, Domenic A Sica, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 DiabetesMary Jane Geiger, Cyrus Mehta, J Rick Turner, et al.
American Heart Journal|March 30, 2013
Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research ConsortiumPhilip Sager, Jeffrey Heilbraun, J Rick Turner, et al.
American Heart Journal|June 15, 2016
The Cardiac Safety Research Consortium enters its second decade: An invitation to participateJ Rick Turner, Peter R Kowey, Ignacio Rodriguez, et al.
American Heart Journal|July 12, 2011
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug AdministrationL Kristin Newby, Ignacio Rodriguez, John Finkle, et al.
American Heart Journal|May 4, 2010
Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later developmentSherene S Min, J Rick Turner, Adel Nada, et al.
American Heart Journal|December 1, 2012
Cardiac imaging approaches to evaluate drug-induced myocardial dysfunctionJennifer B Christian, John K Finkle, Bonnie Ky, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of the American Society of Hypertension : JASH|May 17, 2015
Renal denervation therapy for hypertension: pathways for moving development forwardWilliam B White, Zorina S Galis, Jeffrey Henegar, et al.
American Heart Journal|February 3, 2015
Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac Safety Research ConsortiumJonathan H Seltzer, J Rick Turner, Mary Jane Geiger, et al.
American Heart Journal|December 11, 2017
Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association-cardiac safety research consortium cosponsored think tankHarry A Seifert, Raleigh E Malik, Mondira Bhattacharya, et al.
Journal of the American Society of Hypertension : JASH|November 25, 2014
Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013William B White, J Rick Turner, Domenic A Sica, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 DiabetesMary Jane Geiger, Cyrus Mehta, J Rick Turner, et al.
American Heart Journal|March 30, 2013
Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research ConsortiumPhilip Sager, Jeffrey Heilbraun, J Rick Turner, et al.
American Heart Journal|June 15, 2016
The Cardiac Safety Research Consortium enters its second decade: An invitation to participateJ Rick Turner, Peter R Kowey, Ignacio Rodriguez, et al.
American Heart Journal|July 12, 2011
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug AdministrationL Kristin Newby, Ignacio Rodriguez, John Finkle, et al.
American Heart Journal|May 4, 2010
Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later developmentSherene S Min, J Rick Turner, Adel Nada, et al.
American Heart Journal|December 1, 2012
Cardiac imaging approaches to evaluate drug-induced myocardial dysfunctionJennifer B Christian, John K Finkle, Bonnie Ky, et al.
Pageof 7